BMY-20844

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameBMY-20844
Drug Alias NameBMY-20844
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action3',5'-cyclic-AMP phosphodiesterases inhibitors
Targets3',5'-cyclic-AMP phosphodiesterases
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBristol-Myers Squibb Company
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A